<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01852669</url>
  </required_header>
  <id_info>
    <org_study_id>LPS001</org_study_id>
    <nct_id>NCT01852669</nct_id>
  </id_info>
  <brief_title>Adjunct Inversion for Lower Pole Stone</brief_title>
  <official_title>A Prospective, Randomized, Double Blind, Controlled Study Comparing Extracorporeal Shock Wave Lithotripsy (ESWL) With and Without Simultaneous Adjunct Controlled Inversion Therapy in the Treatment of Lower Pole Caliceal Stone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Monash University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lam Wah Ee Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Monash University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial comparing extracorporeal shockwave lithotripsy (ESWL)
      with and without simultaneous adjunct controlled inversion therapy in the treatment of lower
      pole caliceal stone.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants Who Are Stone Free at 3 Months</measure>
    <time_frame>3 months</time_frame>
    <description>To compare the effectiveness of simultaneous adjunct controlled inversion therapy during extracorporeal shockwave lithotripsy (ESWL) to that of ESWL alone in the treatment of lower pole caliceal stone as measured by stone-free rate(SFR)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Kidney Stone</condition>
  <arm_group>
    <arm_group_label>Inversion, Hydration, ESWL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ESWL with hydration and inversion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESWL, Hydration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ESWL with hydration</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inversion</intervention_name>
    <description>Patients inverted 30 degree head down in Trendelenburg position</description>
    <arm_group_label>Inversion, Hydration, ESWL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Shock Wave Lithotripsy</intervention_name>
    <description>Shock wave lithotripsy</description>
    <arm_group_label>Inversion, Hydration, ESWL</arm_group_label>
    <arm_group_label>ESWL, Hydration</arm_group_label>
    <other_name>ESWL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydration</intervention_name>
    <description>Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
    <arm_group_label>Inversion, Hydration, ESWL</arm_group_label>
    <arm_group_label>ESWL, Hydration</arm_group_label>
    <other_name>Frusemide 20mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Solitary lower pole caliceal stone which is &gt; 5 mm and &lt; 20mm

          2. Not contraindicated for intravenous urogram (IVU) and subsequent X-rays

          3. Patient able to comply strictly with visits/medications

          4. Patient willing and agrees to enter study

        Exclusion Criteria:

          1. Impaired function of the affected kidney

          2. Gross hydronephrosis of the affected kidney

          3. Associated distal obstruction

          4. Multiple stones

          5. Stone more than 2 cm in size

          6. Diverticular stone

          7. Patients who are contraindicated for extracorporeal shockwave lithotripsy e.g.:
             Pregnancy

          8. Patients who are unable to tolerate the procedure

          9. Significant cardiac condition that does not allow the administration of force
             hydration or inversion.

         10. Uncontrolled hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liong Men Long, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lam Wah Ee Hospital</affiliation>
  </overall_official>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2013</study_first_submitted>
  <study_first_submitted_qc>May 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2013</study_first_posted>
  <results_first_submitted>April 6, 2015</results_first_submitted>
  <results_first_submitted_qc>April 17, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 20, 2015</results_first_posted>
  <last_update_submitted>April 17, 2015</last_update_submitted>
  <last_update_submitted_qc>April 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Monash University</investigator_affiliation>
    <investigator_full_name>Shaun Lee Wen Huey</investigator_full_name>
    <investigator_title>Senior Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Inversion, Hydration, ESWL</title>
          <description>ESWL with hydration and inversion
Inversion: Patients inverted 30 degree head down in Trendelenburg position
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
        <group group_id="P2">
          <title>ESWL, Hydration</title>
          <description>ESWL with hydration
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="68">Randomisation error. Patient has protocol violation which necessitated exclusion from analysis</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Inversion, Hydration, ESWL</title>
          <description>ESWL with hydration and inversion
Inversion: Patients inverted 30 degree head down in Trendelenburg position
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
        <group group_id="B2">
          <title>ESWL, Hydration</title>
          <description>ESWL with hydration
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="71"/>
            <count group_id="B2" value="68"/>
            <count group_id="B3" value="139"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.3" spread="11.1"/>
                    <measurement group_id="B2" value="50.9" spread="12.9"/>
                    <measurement group_id="B3" value="49.63" spread="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants Who Are Stone Free at 3 Months</title>
        <description>To compare the effectiveness of simultaneous adjunct controlled inversion therapy during extracorporeal shockwave lithotripsy (ESWL) to that of ESWL alone in the treatment of lower pole caliceal stone as measured by stone-free rate(SFR)</description>
        <time_frame>3 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Inversion, Hydration, ESWL</title>
            <description>ESWL with hydration and inversion
Inversion: Patients inverted 30 degree head down in Trendelenburg position
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
          </group>
          <group group_id="O2">
            <title>ESWL, Hydration</title>
            <description>ESWL with hydration
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Are Stone Free at 3 Months</title>
          <description>To compare the effectiveness of simultaneous adjunct controlled inversion therapy during extracorporeal shockwave lithotripsy (ESWL) to that of ESWL alone in the treatment of lower pole caliceal stone as measured by stone-free rate(SFR)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
                <count group_id="O2" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Inversion, Hydration, ESWL</title>
          <description>ESWL with hydration and inversion
Inversion: Patients inverted 30 degree head down in Trendelenburg position
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
        <group group_id="E2">
          <title>ESWL, Hydration</title>
          <description>ESWL with hydration
Shock Wave Lithotripsy: Shock wave lithotripsy
Hydration: Hydration of patient with 0.5L NaCl and 20mg frusemide IV</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="71"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Shaun Lee</name_or_title>
      <organization>Monash University</organization>
      <phone>55145890</phone>
      <email>shaun.lee@monash.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

